Birdwatch Note
2024-09-25 19:56:08 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Zitat aus der genannten Studie "Impfungen sind ein Eckpfeiler der öffentlichen Gesundheit bei der Eindämmung der SARS-CoV-2-Pandemie. Myokarditis ist eine seltene Komplikation von mRNA-Impfstoffen." Vornehmlich sind Jugendliche ab 16 betroffen, nicht speziell Kinder. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00388-2/fulltext
Written by 937533990C0FEFCE396AC3873457C95C0DBCD597D08CD2AFF9AD29BBDEAD0DBB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1838896482973315193
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1839031151790547033
- noteId - 1839031151790547033
- participantId -
- noteAuthorParticipantId - 937533990C0FEFCE396AC3873457C95C0DBCD597D08CD2AFF9AD29BBDEAD0DBB Participant Details
- createdAtMillis - 1727294168790
- tweetId - 1838896482973315193
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Zitat aus der genannten Studie "Impfungen sind ein Eckpfeiler der öffentlichen Gesundheit bei der Eindämmung der SARS-CoV-2-Pandemie. Myokarditis ist eine seltene Komplikation von mRNA-Impfstoffen." Vornehmlich sind Jugendliche ab 16 betroffen, nicht speziell Kinder. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00388-2/fulltext
Note Ratings
| rated at | rated by | |
| 2024-09-27 06:55:35 -0500 | Rating Details | |
| 2024-09-26 15:26:12 -0500 | Rating Details | |
| 2024-09-26 13:23:03 -0500 | Rating Details | |
| 2024-09-26 12:47:30 -0500 | Rating Details | |
| 2024-09-26 12:21:27 -0500 | Rating Details | |
| 2024-09-26 08:57:51 -0500 | Rating Details | |
| 2024-09-26 06:17:52 -0500 | Rating Details | |
| 2024-09-26 05:55:33 -0500 | Rating Details | |
| 2024-09-26 04:53:02 -0500 | Rating Details | |
| 2024-09-26 04:50:14 -0500 | Rating Details | |
| 2024-09-26 04:35:07 -0500 | Rating Details | |
| 2024-09-26 04:35:07 -0500 | Rating Details | |
| 2024-09-26 04:07:44 -0500 | Rating Details | |
| 2024-09-26 03:55:50 -0500 | Rating Details | |
| 2024-09-26 03:52:54 -0500 | Rating Details | |
| 2024-09-26 03:51:00 -0500 | Rating Details | |
| 2024-09-26 03:47:25 -0500 | Rating Details | |
| 2024-09-26 03:05:01 -0500 | Rating Details | |
| 2024-09-26 00:56:33 -0500 | Rating Details | |
| 2024-09-26 00:44:44 -0500 | Rating Details | |
| 2024-09-26 00:41:12 -0500 | Rating Details | |
| 2024-09-26 00:12:38 -0500 | Rating Details | |
| 2024-09-25 21:04:12 -0500 | Rating Details | |
| 2024-09-25 20:41:14 -0500 | Rating Details | |
| 2024-09-25 18:20:39 -0500 | Rating Details | |
| 2024-09-25 18:00:02 -0500 | Rating Details | |
| 2024-09-25 17:42:22 -0500 | Rating Details | |
| 2024-09-25 16:30:33 -0500 | Rating Details | |
| 2024-09-25 15:55:30 -0500 | Rating Details | |
| 2024-09-25 15:38:04 -0500 | Rating Details | |
| 2024-09-25 15:25:28 -0500 | Rating Details | |
| 2024-09-25 15:14:23 -0500 | Rating Details | |
| 2024-09-27 01:38:00 -0500 | Rating Details | |
| 2024-09-26 18:56:23 -0500 | Rating Details | |
| 2024-09-26 18:21:50 -0500 | Rating Details | |
| 2024-09-26 15:44:27 -0500 | Rating Details | |
| 2024-09-26 05:26:48 -0500 | Rating Details | |
| 2024-09-26 03:56:23 -0500 | Rating Details | |
| 2024-09-26 03:35:20 -0500 | Rating Details | |
| 2024-09-26 03:08:20 -0500 | Rating Details | |
| 2024-09-26 01:14:28 -0500 | Rating Details |